Avid Bioservices Inc (CDMO)

[patientlywaiting]

I've revised my last post!

We now have two sentences from PPHM that to me seem contradictory to each other.

"The interim analysis results demonstrated that the bavituximab plus docetaxel combination group is unlikely to achieve the assumptions established at the initiation of the trial."

Followed by:

"This analysis also showed that the bavituximab combination group is performing as expected according to the original trial assumptions in terms of overall survival........"

I don't get it? who would like to explain this? TIA